Patent ID: 11939300
Assignee: IMMUNOMOLECULAR THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. A method of treating an autoimmune disease selected from the group consisting of celiac disease, type 1 diabetes (T1D), Stiff-person syndrome (SPS), Addison's disease (AD), Schmidt syndrome (SS), and Myasthenia gravis (MG), in a subject in need thereof, comprising the steps of:
(a) identifying a subject having anti-transglutaminase antibodies, antibodies against deamidated gliadin peptides, antibodies against acetylcholine receptor, and/or anti-endomysium antibodies; and
(b) administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 1.